Danish drugmaker Novo Nordisk, the world’s top insulin supplier, expects to be ahead of the pack now nuclear sanctions are lifted in Iran, thanks to a continuous presence and a pre-emptive investment plan.
Read more.
Source: Reuters
Filed Under: Drug Discovery